Biote Corp. Class A Common Stock (BTMD)

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components develo…

Sector

Health Care

Industry

Medicinal Chemicals and Botanical Products

Employees

223

Website

haymakeracquisition.com/

Fundamentals

1-day range

$1.57$1.69

Market cap

$86.06M

P/E (trailing)

3.39

P/E (forward)

3.49

EPS (trailing)

$0.44

Dividend yield

—

Beta

1.65

Avg. volume

314.9K

Forecasts

5 analyst ratings

Biote Corp. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• BTMD

  Biote Corp. Class A Common Stock

  $1.58

  ▼ 3.37%
  Market cap $86.06MP/E 3.39
  $1.27$3.62
• ISPR

  Ispire Technology Inc. Common Stock

  $1.42

  ▲ 1.43%
  Market cap $92.99MP/E —
  $1.01$3.87
• FTLF

  FitLife Brands Inc. Common Stock

  $9.79

  ▼ 1.95%
  Market cap $95.88MP/E 17.43
  $8.67$20.98
• UPXI

  Upexi Inc. Common Stock

  $1.08

  ▼ 6.49%
  Market cap $58.76MP/E 1.41
  $0.54$9.12
• MTEX

  Mannatech Incorporated Common Stock

  $6.74

  ▲ 6.48%
  Market cap $9.55MP/E —
  $3.8$12.45
• BON

  Bon Natural Life Limited Class A Ordinary Shares

  $1.14

  ▲ 0.44%
  Market cap $9.02MP/E —
  $1.05$3.4
• AKAN

  Akanda Corp. Common Shares

  $4.07

  ▼ 3.78%
  Market cap $2.92MP/E —
  $2.29$209.03

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Wednesday's After-Market Session
  Benzinga · 8/12/2026
• B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
  Benzinga · 8/10/2026
• TD Cowen Maintains Buy on Biote, Lowers Price Target to $2
  Benzinga · 8/7/2026
• 12 Health Care Stocks Moving In Thursday's Intraday Session
  Benzinga · 8/6/2026
• Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ...
  Yahoo · 8/6/2026
• biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• biote Corp. (BTMD) Reports Break-Even Earnings for Q2
  Yahoo · 8/6/2026
• biote Q2 Earnings Call Highlights
  Yahoo · 8/5/2026

• Beer Marc D · August 11, 2026 · Buy

  16.0K @ $1.55
• Beer Marc D · August 10, 2026 · Buy

  116.0K @ $1.53
• Peterson Robert Charles · June 12, 2026 · Grant

  206.7K
• Christensen Bret · June 8, 2026 · Grant

  130.0K
• Beer Marc D · June 8, 2026 · Grant

  114.2K
• Andrew R. Heyer · May 12, 2026 · Grant

  130.0K
• Andrew R. Heyer · May 12, 2026 · Grant

  35.3K
• Cone Stephen Mark · May 12, 2026 · Grant

  130.0K
• Cone Stephen Mark · May 12, 2026 · Grant

  31.5K
• Jacoby Dana Lynn · May 12, 2026 · Grant

  130.0K
• Jacoby Dana Lynn · May 12, 2026 · Grant

  37.8K
• Debra L. Morris · May 12, 2026 · Grant

  130.0K
• Debra L. Morris · May 12, 2026 · Grant

  39.0K
• Debra L. Morris · May 12, 2026 · Option Exercise

  21.4K
• Barrera Richard R · May 12, 2026 · Grant

  121.5K

Institutional Ownership

March 31, 2026

Total shares held

14.84M

Total value held

$19.09M

Institutional holders

80